Raynovent is based in Guangzhou, China. It has raised $54M in total funding. Latest round: Series C. Backed by Efung Capital, Yide Fund.
Raynovent is based in Guangzhou, China. Raynovent has raised $54M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2023. The round record for Raynovent runs through 2023; nothing later has been disclosed. Investors on record include Efung Capital, Yide Fund. 2 distinct backers are named across the disclosed rounds.
We update the Raynovent record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Guangzhou and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026